ldinvest Partners announces the successfuliPO of Prosensa Holding B.V. a healthcare portfolio company. on the New-York Nasdaq.
On Friday June 28th, Prosensa Holding B.V. [Prosensal initiated its first trading day on the New-York Nasdaq, USA. Prosensa is the second ldinvest Biotech portfolio company completing a market listing this year. Earlier in 2013, Erytech Pharma, a French company specialized in innovative therapeutic approach for cancers was admitted on NYSE Euronext Paris.
Download the pdf file